{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:34:55Z","timestamp":1792172095268,"version":"4.4.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.contraception.2024.110450","type":"journal-article","created":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T08:02:48Z","timestamp":1712822568000},"page":"110450","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Heavy menstrual bleeding in women with inherited bleeding disorders in use of LNG-IUS: A systematic review and single-arm meta-analysis"],"prefix":"10.1016","volume":"135","author":[{"given":"Juliana Almeida","family":"Oliveira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine","family":"Eskandar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fanea","family":"Chagas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livia Leni de Oliveira","family":"do Nascimento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Dias","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Luiza Lunardi","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fl\u00e1via Ribeiro","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2024.110450_bib1","unstructured":"Jonas B. Inherited blood disorders [Internet]. UC Davis Health. 2023 [cited Feb 26,\u00a02024]. Available from: \u3008https:\/\/health.ucdavis.edu\/conditions\/blood-disorders\/inherited-blood-disorders\u3009."},{"issue":"2","key":"10.1016\/j.contraception.2024.110450_bib2","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1016\/j.jogc.2017.11.036","article-title":"No. 163-Gynaecological and obstetric management of women with inherited bleeding disorders","volume":"40","author":"Demers","year":"2018","journal-title":"J Obstet Gynaecol Can"},{"issue":"12","key":"10.1016\/j.contraception.2024.110450_bib3","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1177\/0961203306071706","article-title":"Treatment of menorrhagia associated with oral anticoagulation: efficacy and safety of the levonorgestrel releasing intrauterine device (Mirena coil)","volume":"15","author":"Pisoni","year":"2006","journal-title":"Lupus"},{"issue":"6","key":"10.1016\/j.contraception.2024.110450_bib4","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1111\/jth.15311","article-title":"They don\u2019t really take my bleeds seriously\u201d: barriers to care for women with inherited bleeding disorders","volume":"19","author":"Arya","year":"2021","journal-title":"J Thromb Haemost"},{"issue":"3","key":"10.1016\/j.contraception.2024.110450_bib5","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/hae.14221","article-title":"Managing women\u2010specific bleeding in inherited bleeding disorders: a multidisciplinary approach","volume":"27","author":"Mauser\u2010Bunschoten","year":"2021","journal-title":"Haemophilia"},{"key":"10.1016\/j.contraception.2024.110450_bib6","unstructured":"ACOG. Heavy Menstrual Bleeding [Internet]. The American College of Obstetricians and Gynecologists. 2022 [cited Feb 23, 2024]. Available from: \u3008https:\/\/www.acog.org\/womens-health\/faqs\/heavy-menstrual-bleeding\u3009."},{"issue":"6","key":"10.1016\/j.contraception.2024.110450_bib7","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/hae.14643","article-title":"Gynaecological management of women with inherited bleeding disorders. A UK Haemophilia Centres Doctors\u2019 Organisation Guideline","volume":"28","author":"Curry","year":"2022","journal-title":"Haemophilia"},{"issue":"3","key":"10.1016\/j.contraception.2024.110450_bib8","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1097\/AOG.0000000000003411","article-title":"Screening and management of bleeding disorders in adolescents with heavy menstrual bleeding: ACOG Committee Opinion, Number 785","volume":"134","year":"2019","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.contraception.2024.110450_bib9","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.contraception.2020.05.009","article-title":"Use of a levonorgestrel 52-mg intrauterine system in the control of abnormal uterine bleeding in women with inherited bleeding disorders","volume":"102","author":"Campos","year":"2020","journal-title":"Contraception"},{"issue":"6","key":"10.1016\/j.contraception.2024.110450_bib10","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/hae.12184","article-title":"Malposition and expulsion of the levonorgestrel intrauterine system among women with inherited bleeding disorders","volume":"19","author":"Rimmer","year":"2013","journal-title":"Haemophilia"},{"issue":"4","key":"10.1016\/j.contraception.2024.110450_bib11","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jpag.2016.04.001","article-title":"Levonorgestrel-releasing intrauterine device use in female adolescents with heavy menstrual bleeding and bleeding disorders: single institution review","volume":"30","author":"Adeyemi-Fowode","year":"2017","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"2","key":"10.1016\/j.contraception.2024.110450_bib12","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jadohealth.2022.02.018","article-title":"Does a bleeding disorder lessen the efficacy of the 52-mg levonorgestrel-releasing intrauterine system for heavy menstrual bleeding in adolescents? A retrospective multicenter study","volume":"71","author":"Khalighi","year":"2022","journal-title":"J Adolesc Health"},{"issue":"12","key":"10.1016\/j.contraception.2024.110450_bib13","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1111\/j.1471-0528.2004.00305.x","article-title":"The use of levonorgestrel\u2010releasing intrauterine system for treatment of menorrhagia in women with inherited bleeding disorders","volume":"111","author":"Kingman","year":"2004","journal-title":"BJOG Int J Obstet Gynaecol"},{"issue":"3","key":"10.1016\/j.contraception.2024.110450_bib14","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.contraception.2010.07.010","article-title":"Levonorgestrel-releasing intrauterine system for the management of heavy menstrual bleeding in women with inherited bleeding disorders: long-term follow-up","volume":"83","author":"Chi","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2024.110450_bib15","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2024.110450_bib16","unstructured":"Higgins\u00a0J,\u00a0Thomas\u00a0J,\u00a0Chandler\u00a0J,\u00a0Cumpston\u00a0M,\u00a0Li\u00a0T,\u00a0Page\u00a0M,\u00a0et al. Cochrane handbook for systematic reviews of interventions [Internet]. Cochrane. 2023 [cited Feb 27,\u00a02024]. Available from: \u3008https:\/\/training.cochrane.org\/handbook\/current\u3009."},{"key":"10.1016\/j.contraception.2024.110450_bib17","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.contraception.2024.110450_bib18","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1177\/0962280216669183","article-title":"Optimally estimating the sample mean from the sample size, median, mid-range, and\/or mid-quartile range","volume":"27","author":"Luo","year":"2018","journal-title":"Stat Methods Med Res"},{"issue":"1","key":"10.1016\/j.contraception.2024.110450_bib19","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"issue":"7","key":"10.1016\/j.contraception.2024.110450_bib20","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1111\/jth.13349","article-title":"Combined oral contraceptives, thrombophilia and the risk of venous thromboembolism: a systematic review and meta\u2010analysis","volume":"14","author":"Van Vlijmen","year":"2016","journal-title":"J Thromb Haemost"},{"issue":"3","key":"10.1016\/j.contraception.2024.110450_bib21","first-page":"809","article-title":"Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism","volume":"86","author":"Emmerich","year":"2001","journal-title":"Thromb Haemost"},{"issue":"3","key":"10.1016\/j.contraception.2024.110450_bib22","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1538-7836.2004.00606.x","article-title":"Impact of environmental and hereditary risk factors on the clinical manifestation of thrombophilia in homozygous carriers of factor V:G1691A","volume":"2","author":"Ehrenforth","year":"2004","journal-title":"J Thromb Haemost JTH"},{"issue":"12","key":"10.1016\/j.contraception.2024.110450_bib23","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1053\/euhj.2001.3082","article-title":"Venous thromboembolism in young women; role of thrombophilic mutations and oral contraceptive use","volume":"23","author":"Legnani","year":"2002","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.contraception.2024.110450_bib24","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s13669-023-00357-8","article-title":"Intrauterine device complications and their management","volume":"12","author":"Myo","year":"2023","journal-title":"Curr Obstet Gynecol Rep"},{"issue":"6","key":"10.1016\/j.contraception.2024.110450_bib25","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.contraception.2021.02.013","article-title":"Relationship of parity and prior cesarean delivery to levonorgestrel 52 mg intrauterine system expulsion over 6 years","volume":"103","author":"Gilliam","year":"2021","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.contraception.2024.110450_bib26","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/AOG.0000000000000144","article-title":"Effects of age, parity, and device type on complications and discontinuation of intrauterine devices","volume":"123","author":"Aoun","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.contraception.2024.110450_bib27","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jpag.2020.11.003","article-title":"Rates of intrauterine device expulsion among adolescents and young women","volume":"34","author":"Keenahan","year":"2021","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"6","key":"10.1016\/j.contraception.2024.110450_bib28","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1097\/AOG.0000000000005000","article-title":"Demographic, reproductive, and medical risk factors for intrauterine device expulsion","volume":"140","author":"Anthony","year":"2022","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2024.110450_bib29","doi-asserted-by":"crossref","unstructured":"Agarwal\u00a0M,\u00a0Singh\u00a0S,\u00a0Sinha\u00a0S,\u00a0Sinha\u00a0HH.\u00a0Comparison of bleeding pattern and quality of life before and after the insertion of a levonorgestrel intrauterine system for heavy menstrual bleeding: a seven-year review. Cureus [Internet]. 2023 Mar 14 [cited Feb 29, 2024]; Available from: \u3008https:\/\/www.cureus.com\/articles\/143792-comparison-of-bleeding-pattern-and-quality-of-life-before-and-after-the-insertion-of-a-levonorgestrel-intrauterine-system-for-heavy-menstrual-bleeding-a-seven-year-review\u3009.","DOI":"10.7759\/cureus.36142"},{"key":"10.1016\/j.contraception.2024.110450_bib30","doi-asserted-by":"crossref","unstructured":"Bofill Rodriguez\u00a0M,\u00a0Lethaby\u00a0A,\u00a0Jordan\u00a0V.\u00a0Progestogen-releasing intrauterine systems for heavy menstrual bleeding. Cochrane Gynaecology and Fertility Group, editor. Cochrane Database Syst Rev [Internet]. 2020 Jun 12 [cited Feb 29, 2024];2020(6). Available from: http:\/\/doi.wiley.com\/10.1002\/14651858.CD002126.pub4.","DOI":"10.1002\/14651858.CD002126.pub4"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782424001136?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782424001136?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T21:35:18Z","timestamp":1717191318000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782424001136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":30,"alternative-id":["S0010782424001136"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2024.110450","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heavy menstrual bleeding in women with inherited bleeding disorders in use of LNG-IUS: A systematic review and single-arm meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2024.110450","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110450"}}